Login / Signup

Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression.

Timotius Ivan HariyantoAndree Kurniawan
Published in: Journal of diabetes and metabolic disorders (2021)
The online version contains supplementary material available at 10.1007/s40200-021-00777-4.
Keyphrases
  • coronavirus disease
  • systematic review
  • meta analyses
  • respiratory syndrome coronavirus
  • social media
  • health information
  • psychometric properties
  • sars cov
  • randomized controlled trial